Clinical Trial Update: Acamprosate: Genes Associated With Response

View source ↗

Summary

A Mayo Clinic–sponsored study on acamprosate examining genetic factors associated with response in alcoholism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism

Drugs mentioned

• Campral (acamprosate)

Snippet

Sponsor: Mayo Clinic | Conditions: Alcoholism | Status: COMPLETED